Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Choosing your first blue chip crypto involves assessing liquidity, security, and use cases. This starter guide walks you through simple decision criteria.
25,502 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Markets reassess the Warsh era as fresh inflation figures arrive. Inflation data confirms kevin and pushes investors ...
SpaceX launches a high-profile IPO today, sending shares up and prompting a split in sentiment among residents near S...
Anthropic aims to go public this fall, but mounting regulatory pressures risk undercutting its valuation. Investors a...
DTE Energy is nearing its 52-week high after a robust first half of 2026, supported by utility earnings and a rising ...
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Elon Musk signals a shift in hiring, prioritizing conversation over credentials with a rule he describes as don’t loo...
Fraudsters increasingly impersonate seniors to access bank funds. Learn how the posed elderly account holder scam unf...
A glossy online romance with a powerful royal figure can feel thrilling—until the bills arrive. This article explains...
Inflation just 3-year high is reshaping everyday costs and the profit path for credit card lenders. This guide explai...
Meta Platforms is signaling a durable AI-led growth path through vertical control of compute, power, silicon, and ads...
As retirees start receiving benefits, many are surprised by smaller checks. This piece breaks down the key reasons yo...